Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors - The Light Study

Description:

The goal of the trial was to evaluate treatment with naltrexone/bupropion compared with placebo among overweight/obese individuals with diabetes and/or other cardiovascular risk factors.